Blood cancers

Cancer units should prepare for the next transmission phase: experts

Sponsored by Janssen-Cilag Pty Ltd

Haematologists will need to make hard calls about delaying some cancer therapies, moving to shorter treatment regimens and prioritising treatment to only those most at risk if community acquired COVID-19 transmission rates start to climb, according to new clinical guidance. During a SARS-COV-2 (COVID-19) webinar sponsored by Janssen-Cilag to discuss the management of cancer patients ...

Already a member?

Login to keep reading.

© 2021 the limbic